Innate Pharma IPHA
NASDAQ IPHA
$1.59 -0.04 (-2.45%)
At close: Oct 1, 2026 · 4:00 PM EDT

Innate Pharma (IPHA) Change in Account Payables (2024 - 2025)

Updated

Innate Pharma (IPHA) recorded Change in Account Payables of -$17.51 million in the quarter ended Dec 31, 2025, compared with -$17.11 million a year earlier.

Analysis

Innate Pharma (IPHA) Change in Account Payables (2024 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Innate Pharma reported Change in Account Payables of -$1.09 million.

  • Across earlier years, Change in Account Payables came in at -$1.09 million in the year ended Dec 31, 2024, -$18.41 million in the year ended Dec 31, 2023, -$22.04 million in the year ended Dec 31, 2022 and -$32.69 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -70.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -66.70 Mn
10 Innate Pharma 152.76 Mn 152.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -17.51 Mn
Dec 31, 2024 -17.11 Mn
API Access

Innate Pharma Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=IPHA&period=max&api_key=YOUR_API_KEY